Keloid
Information
- Disease name
- Keloid
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT04915391 | Active, not recruiting | Restenosis in Coronary Stents And Cutaneous HEaLing | April 25, 2017 | April 30, 2023 | |
NCT05330078 | Active, not recruiting | Early Phase 1 | Examining the Therapeutic Potential of Botulinum Toxin Type A in the Treatment of Keloids | March 11, 2022 | January 2032 |
NCT04988022 | Active, not recruiting | Phase 4 | Dupilumab in the Treatment of Keloids | May 25, 2021 | April 2025 |
NCT04722263 | Active, not recruiting | Early Phase 1 | Radiotherapy for Keloids | December 1, 2020 | December 2024 |
NCT04582305 | Active, not recruiting | Phase 4 | Bleomycin Jet Injections in Keloids | March 18, 2022 | March 30, 2023 |
NCT00754247 | Completed | Phase 4 | A Randomized Comparative Study Evaluating the Tolerability and Efficacy of Two Topical Therapies for the Treatment of Keloids and Hypertrophic Scars | March 2006 | February 2008 |
NCT00836147 | Completed | Phase 1/Phase 2 | Exploratory Study of the Efficacy and Safety of Juvista 250ng When Administered Following Excision of Ear Lobe Keloids | February 2009 | June 2010 |
NCT01125137 | Completed | N/A | Case-control Study on Matrix Metalloproteinase Levels in Tissue in Patients With Keloid Scar | February 2010 | January 2011 |
NCT00008502 | Completed | Genetic Analysis of Familial Keloids | August 14, 2001 | November 28, 2017 | |
NCT00129428 | Completed | Phase 1/Phase 2 | Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix | August 2002 | January 2009 |
NCT00469235 | Completed | Phase 1/Phase 2 | Trial of Juvista (Avotermin) Following Removal of Ear Lobe Keloid Scars | June 2007 | May 2009 |
NCT00587587 | Completed | Phase 1/Phase 2 | A Pilot Study of Apligraf for the Treatment and Prevention of Recurrence of Excised Keloids | December 2007 | March 2010 |
NCT00710333 | Completed | Phase 1/Phase 2 | Safety of Juvista When Administered Following Excision of Ear Lobe Keloids | July 2008 | December 2009 |
NCT01446770 | Completed | Phase 2 | Evaluation of the Initial Safety and Efficacy of Keloid Lesions Treated With MF-4181 | November 2010 | December 2011 |
NCT01789346 | Completed | N/A | Pilot Study of a Novel 532nm KTP Laser for the Treatment of Fresh Surgical Scars | February 2013 | December 2014 |
NCT01941914 | Completed | Phase 1 | Calcium Electroporation for the Treatment of Keloids | August 2013 | May 1, 2018 |
NCT01994616 | Completed | Prospective Evaluation of the Use of Intralesional Cryotherapy for Treatment of Keloid and Hypertrophic Scars | January 2009 | June 2011 | |
NCT02005055 | Completed | High Dose Rate Brachytherapy for Treatment of Keloids | January 2003 | December 2010 | |
NCT02063243 | Completed | N/A | Intralesional Cryotherapy With a Argon Gas Based Device for the Treatment of Keloid and Hypertrophic Scars | January 2010 | January 2012 |
NCT02079168 | Completed | Phase 2 | A Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults | March 2014 | March 2016 |
NCT02340325 | Completed | Phase 1 | FS2 Safety and Tolerability Study in Healthy Volunteers | May 2015 | January 2016 |
NCT02630303 | Completed | Phase 1 | High Fluence Light Emitting Diode-Red Light (LED-RL) in Human Skin | January 2016 | March 2017 |
NCT02922972 | Completed | N/A | Treatment of Keloid Scar by Autologous Platelet Rich Plasma Obtained With RgenKit-BCT | September 2014 | September 2017 |
NCT02996097 | Completed | N/A | Fractional Laser Assisted Steroid Therapy vs Intralesional Steroids in the Treatment of Keloids | April 2016 | June 15, 2018 |
NCT03160053 | Completed | N/A | Improving Keloids Using Targeted Ultraviolet-B Irradiation | June 23, 2015 | June 15, 2018 |
NCT03228693 | Completed | N/A | Gene Expression and Biomarker Profiling of Keloid Skin | September 11, 2017 | January 31, 2023 |
NCT03239964 | Completed | Phase 4 | Surgical Excision and Intralesional Steroid Injection for Prevention of Post Caesarean Keloid Recurrence | August 10, 2016 | January 24, 2018 |
NCT03460431 | Completed | N/A | A Study Using Fractional Carbon Dioxide and Long Pulsed Neodymium-yttrium Aluminum Garnet Lasers in Treatment of Keloids | July 1, 2014 | June 30, 2017 |
NCT03601052 | Completed | Phase 2 | Efficacy, Safety, and Tolerability of Remlarsen (MRG-201) Following Intradermal Injection in Subjects With a History of Keloids | June 11, 2018 | June 24, 2020 |
NCT03630198 | Completed | Phase 4 | Pain Outcomes Following Intralesional Corticosteroid Injections | October 1, 2018 | September 1, 2019 |
NCT03795116 | Completed | Phase 2 | Light Emitting Diode-Red Light (LED-RL) Phototherapy for Skin Scarring Prevention | March 18, 2019 | October 26, 2020 |
NCT03887208 | Completed | Phase 1/Phase 2 | Therapy of Scars and Cutis Laxa With Autologous Adipose Derived Mesenchymal Stem Cells | January 31, 2018 | January 18, 2020 |
NCT04049552 | Completed | Early Phase 1 | RAPA-Keloid Study of Keloid Regression | January 24, 2020 | May 2, 2021 |
NCT04169438 | Completed | N/A | Pilot Study Investigating a Restorative Wound Care Cream Together With Petrolatum on Surgical Excisions | November 5, 2019 | September 29, 2020 |
NCT04169490 | Completed | N/A | "A Clinical Study Investigating the Effectiveness of OTC Scar-management Modalities" | February 7, 2019 | November 3, 2020 |
NCT04553159 | Completed | Phase 2 | Autologous Adipose Derived Stem Cells Transplantation in the Treatment of Keloids. | March 1, 2021 | June 16, 2021 |
NCT04710719 | Completed | N/A | Post-Surgical Injection With Triamcinolone Versus Triamcinolone/Fluorouracil in Treatment of Keloids | February 1, 2021 | July 1, 2022 |
NCT04827875 | Completed | Phase 1 | Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy | June 23, 2021 | December 15, 2022 |
NCT04844840 | Completed | Phase 2 | A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid Recurrence | April 29, 2021 | May 17, 2023 |
NCT05275699 | Completed | Phase 1/Phase 2 | Analyse of Diagnosis Value of Keloid on 68Ga- FAPI-04 PET-CT | March 1, 2022 | February 1, 2023 |
NCT05412745 | Completed | N/A | Class I Medical Device on Post-surgical Scars | May 1, 2022 | September 10, 2022 |
NCT05887804 | Completed | Phase 4 | Comparison of Keloid Volume and Symptoms Reduction Between Intralesional Umbilical-Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide Injection as Keloid Therapy: A Randomised Controlled Trial | October 1, 2021 | June 9, 2022 |
NCT05939817 | Completed | Phase 4 | The Effect of Intralesian Injection of Umbilical Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide on Type 1:3 Collagen Ratio and Interleukin-10 Levels in Keloid: A Randomised Controlled Trial | October 1, 2021 | June 9, 2022 |
NCT06034587 | Completed | Multimodal Ultrasound Imaging Assessment on Keloid | July 21, 2021 | August 30, 2023 | |
NCT04824612 | Enrolling by invitation | N/A | Photobiomodulation and the Intralesional Administration of Corticoid in the Keloid Surgery. | August 30, 2021 | January 2024 |
NCT05461157 | Enrolling by invitation | N/A | Preoperative Silicone Ointment and Wound Healing | November 14, 2022 | February 2026 |
NCT06230146 | Not yet recruiting | Phase 1/Phase 2 | Efficacy and Safety of Fractional CO2 Laser Combined With Intralesional Insulin, Botulinum Toxin or Triamcinolone Acetonide in the Treatment of Keloid: A Clinical, Dermoscopic and Immunohistochemical Study. | May 1, 2024 | May 1, 2026 |
NCT05893108 | Not yet recruiting | Phase 1/Phase 2 | Ethosomal Gel Bearing Losartan 5% for Keloid Treatment | March 30, 2024 | October 30, 2024 |
NCT01619553 | Recruiting | Genetic Analysis of Keloids | April 2009 | December 2025 | |
NCT01423981 | Recruiting | Web Based Investigation of Natural History of Keloid Disorder, an Online Survey | November 2011 | June 2031 | |
NCT06373458 | Recruiting | Phase 2 | Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy | June 30, 2024 | May 2026 |
NCT05488860 | Recruiting | N/A | Piezoelectric Drived Microneedling in Treating Refractory Skin Diseases | July 30, 2022 | July 31, 2024 |
NCT05128383 | Recruiting | Phase 2 | Study to Assess Efficacy and Safety of Dupilumab in the Treatment of Keloids | January 13, 2023 | December 2025 |
NCT06431360 | Recruiting | N/A | Effect of Strontium-90 Brachytherapy Combined With Hyperthermia in the Treatment of Keloid | May 14, 2024 | June 30, 2025 |
NCT06138964 | Recruiting | Phase 3 | Comparing the Effect of siSPARC Microneedle Patch Versus siSPARC+siLR4A Microneedle Patch on Post-surgical Scars | November 14, 2023 | November 14, 2024 |
NCT01425437 | Terminated | Keloid Tissue Bank | June 2012 | December 2018 | |
NCT00476697 | Terminated | N/A | UVA1 Light for Scleroderma and Similar Conditions | January 1997 | July 2003 |
NCT03760250 | Terminated | Phase 2 | Imiquimod for Preventing Keloid Recurrence | February 5, 2019 | September 1, 2020 |
NCT01478243 | Terminated | Study of Psycho-Social Impact of Keloid | September 2012 | September 2012 | |
NCT01408953 | Terminated | Phase 2 | Therapeutic Study of Bevacizumab Injection Directly Inside the Keloid Tissue | February 2012 | November 2012 |
NCT00519493 | Terminated | N/A | A Randomized Clinical Study Comparing Two Closure Techniques of Excised Keloids | August 2007 | December 2007 |
NCT04593706 | Unknown status | N/A | Comparison of the Efficacy of Different Steroids in the Treatment of Abnormal Scars (Keloids, Hypertrophic Scars) | November 1, 2020 | October 31, 2021 |
NCT01457079 | Unknown status | Keloid Radiation Registry | December 2011 | June 2021 | |
NCT04186273 | Unknown status | Phase 2 | Clinical Safety and Scar Prevention Study of a Topical Antifibrotic Compound FS2. | December 5, 2019 | March 1, 2021 |
NCT04326959 | Unknown status | Phase 1/Phase 2 | Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for Keloid | September 1, 2020 | December 1, 2020 |
NCT04391621 | Unknown status | Phase 2 | Efficacy of Adipose Derived Stromal Vascular Fraction in the Treatment of Keloids | May 1, 2021 | December 31, 2023 |
NCT01423383 | Unknown status | Epidemiology Study of Keloid | September 2011 | December 2021 | |
NCT02823236 | Unknown status | Phase 3 | Efficacy of Intralesional Triamcinolone and 8% Topical Pirfenidone for Treatment of Keloid Scars | October 24, 2016 | May 1, 2020 |
NCT04597060 | Unknown status | N/A | The Safety and Efficacy of Thermo-mechanical System for Fractional Ablation Associated Triamcinolone Acetonide Drug Delivery for the Treatment of Hypertrophic Scars and Keloids | October 2020 | February 2021 |
NCT02923596 | Unknown status | Retrospective Study of Keloid Disorder | September 2016 | September 2023 | |
NCT01158196 | Unknown status | Phase 3 | Safety and Efficacy of Infrared Diode Laser on Improvement of Scar and Prevention of Recurrence of Excised Keloid | June 2010 | June 2013 |
NCT03312166 | Unknown status | N/A | Compressive Device to Prevent Keloïd Scars Recurrence [SCARWARS] | October 3, 2017 | October 10, 2022 |
NCT03433222 | Unknown status | Phase 1 | Phase 1 Study of HF-LED-RL in Fitzpatrick Skin Types I to III | January 31, 2018 | January 8, 2019 |
NCT00565552 | Unknown status | N/A | Influence of a Silicone Gel (Dermatix®) on Thoracic Scar Formation After Harvesting of Autologous Rib Cartilage | January 2007 | January 2009 |
NCT02546076 | Withdrawn | Phase 2 | Comparison of Dual-mode ER:YAG Laser in Patients With Long Keloid/Hypertrophic Scars | May 2016 | January 2017 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D007627